Emil Lou, MD, PhD, FACP
Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation

Contact Info
Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation
Faculty, PhD Program in Integrative Biology and Physiology
Graduate Program Faculty Member, Integrative Biology and Physiology (IBP) Program
Medical Director, Clinical Trials Office - Solid Tumor Unit
Co-leader, MCC Molecular Tumor Board
Gastrointestinal Oncologist; Neuro Oncologist
Medical School, State University of New York (SUNY) Upstate Medical University, Syracuse, NY
Residency, Duke University Medical Center, Durham, NC
Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY
Fellowship, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC
Summary
After completing undergraduate studies in biochemistry at SUNY College at Geneseo, Dr. Lou received his M.D. and Ph.D. degrees (Microbiology and Immunology) from SUNY Upstate Medical University in 2004. He performed his residency training in Internal Medicine at Duke University Medical Center and then subsequently completed his Medical Oncology and Hematology fellowship at the Memorial Sloan-Kettering Cancer Center in 2010. He also completed an additional fellowship in Neuro-Oncology at the Preston Robert Tisch Brain Tumor Center at Duke.
Dr. Lou, a diplomate of the American Board of Internal Medicine, is board certified in Medical Oncology and Internal Medicine. In addition he is also board certified in Neuro-Oncology through the United Council for Neurologic Subspecialties. He joined the faculty in the Division of Hematology, Oncology and Transplantation in 2011 and is a member of the Masonic Cancer Center, University of Minnesota.
Care Philosophy
New Patients
Tips to be a Great Patient Advocate
Awards & Recognition
Professional Associations
Research
Research Summary/Interests
- Role of tunneling nanotubes in intercellular communication and pathophysiology of cancer.
- Biomarkers of drug resistance in cancer
- Genomic markers of exceptional response or non-response to drug therapy in solid tumor malignancies (colorectal cancer and malignant brain tumors)
Clinical
Board Certifications
Board Certifications
- Internal Medicine
- Medical Oncology
- Neuro-oncology
Clinical Interests
Appendix Cancer; Neuroendocrine Tumors; Pancreatic Cancer; Esophageal Cancer; Gastric Cancer; Colorectal Cancer; Cancer Metastasis; Solid Tumor Metastasis to the Brain; Brain Tumors